Skip to main content
. 2022 Jan 15;2022:3279503. doi: 10.1155/2022/3279503

Table 2.

Comparison of the incidence of adverse reactions between the two groups after treatment (n (%)).

Groups N Thrombocytopenia Leukopenia Abnormal liver function Gastrointestinal discomfort Hyperglycemia The total incidence
Study group 52 1 1 0 1 2 5 (9.62)
Control group 52 3 6 0 3 5 17 (32.69)
χ 2 6.144
P <0.05